Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12624000763549
ACTRN12624000763549
Not yet recruiting
未知

A Randomised Controlled Trial Assessing the Efficacy of Intra-operative Rigenera Autologous Micrograft Therapy (AMT) on graft survival, hair follicle density and thickness in FUT Hair Transplant Patients vs placebo

Dr Adam Ellerby0 sites40 target enrollmentJune 21, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAndrogenic alopeciaMetabolic and Endocrine - Other endocrine disordersSkin - Dermatological conditions

Overview

Phase
未知
Intervention
Not specified
Conditions
Androgenic alopecia
Sponsor
Dr Adam Ellerby
Enrollment
40
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 21, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Adam Ellerby

Eligibility Criteria

Inclusion Criteria

  • •Forty patients aged over 25 undergoing FUT hair transplant for androgenetic alopecia (AGA).
  • •Patients selected based on their need for frontal region transplant
  • •Frontal recipient area must have advanced AGA
  • •Medications \- Every patient should be stabilised on hair loss medications (ie slow progression or cessation of hair loss for \>6 months using standard medical therapies)

Exclusion Criteria

  • •Non\-androgenic cause for alopecia \- autoimmune, scaring, thyroid, iron and vitamin D deficiencies.
  • •Previous hair transplant surgery within past 18 months
  • •Other regenerative treatments within past 12 months \- Rigenera, Platelet rich plasma (PRP), Platelet rich fibrin (PRF)
  • •Inter\-current systemic illness or scalp disease \- Human immunodeficiency virus (HIV), Hepatitis, cancer, haematological disease, fungal scalp, dermatitis
  • •Interstate or out of area patients due to in\-person follow up requirements \- New South Wales (NSW) patients only

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
A Randomized Controlled Trial Assessing the Efficacy of iPACK (Interspace Between the Popliteal Artery and Capsule of the Knee) Block for Postoperative Analgesia in Simultaneous Bilateral Total Knee Arthroplastypostoperative pain after total knee arthroplastyknee function recoverycomplicationstotal knee arthroplastybilateral one-stageInterspace Between the Popliteal Artery and Capsule of the Knee (iPACK)periarticular injection (PAI)postoperative analgesia
TCTR20210223002/A40
Recruiting
Phase 4
A Randomized Controlled Trial Assessing the Efficacy and Safety Profile of Oral Ziliv Among Patients with Hepatic Disease Attending the Gastrointestinal Clinic of the Lagos University Teaching Hospital, Idi-ArabaDigestive SystemHEPATOLOGY-LIVER HEALTH
PACTR202107709749875Zifam Pinnacle Nigeria Ltd100
Terminated
Not Applicable
Evaluating a Computer-based Inhibitory Smoking Training (INST) program to assist individuals to quit or reduce smoking.SmokingAddictionNicotine dependence
ACTRN12617000252314Associate Professor Petra Staiger150
Completed
Phase 2
Psychological Intervention for Childhood Emotional and Behavioural Problems
ACTRN12619000084189Irene Serfaty30
Not yet recruiting
Phase 4
A Randomised Controlled Trial of Subacromial Local Anaesthetic Delivery Following Rotator Cuff Surgery (SALAD Trial)
ACTRN12623001091695Sydney Local Health District96